脑肿瘤术后减少外源性类固醇逐渐减量方案:一项病例对照研究
本研究在单术者脑肿瘤术后患者中实施减少外源性类固醇逐渐减量方案(REST,地塞米松38.5 mg、10天减量),并与历史对照的高剂量减量方案(地塞米松117 mg、17天减量)按基线特征匹配比较。每组25例,REST组地塞米松中位用量34.5 mg(四分位距32-41 mg)低于对照组43 mg(四分位距16-91 mg)(P=0.04)。REST组新发或加重高血压发生率0%显著低于对照组20%(P=0.02),糖尿病、失眠、住院时间和30天再入院率无差异。
要点
- REST方案(地塞米松38.5 mg、10天减量)较117 mg、17天减量方案降低地塞米松中位用量。
- REST组新发或加重高血压发生率0%显著低于对照组20%(P=0.02)。
- 两组糖尿病、失眠、住院时间和30天再入院率无显著差异。
核心结论
- 脑肿瘤术后减少类固醇逐渐减量较对照组高剂量减量显著降低高血压发生率,且不增加住院时间或30天再入院率。
研究设计与样本
- 病例对照研究,单术者术后脑肿瘤患者接受REST方案(地塞米松38.5 mg、10天减量),历史对照接受高剂量减量方案(地塞米松117 mg、17天减量)并按基线特征匹配。
主要发现
- 每组25例,基线特征无显著差异。
- REST组地塞米松中位用量34.5 mg(四分位距32-41 mg)低于对照组43 mg(四分位距16-91 mg)(P=0.04)。
- REST组新发或加重高血压发生率0%低于对照组20%(P=0.02)。
- 糖尿病、失眠、住院时间和30天再入院率两组无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dexamethasone is a standard treatment for cerebral edema after brain tumor surgery. However, its side effects can negatively impact the quality and safety of care provided to patients. Sparse evidence exists in the literature regarding postoperative steroid dosing to guide clinicians. The objective of this study was to determine if a new reduced exogenous steroid taper (REST) protocol would effectively treat postoperative cerebral edema while reducing the incidence of steroid-related side effects including diabetes, hypertension, and insomnia. METHODS: A REST protocol (dexamethasone 38.5 mg tapered over 10 days) was instituted for patients with postoperative brain tumor of a single surgeon. Historical controls treated with a high-dose taper (dexamethasone 117 mg taper over 17 days) were selected to match for baseline characteristics. Outcomes of new or worsened diabetes, hypertension, and insomnia, as well as length of stay (LOS) and 30-day readmission rates, were compared. RESULTS: Twenty-five patients were included in each group. There were no significant differences in baseline characteristics. The REST group received a median of 34.5 mg (interquartile range, 32-41 mg) of dexamethasone, whereas controls received 43 mg (interquartile range, 16-91 mg) (P = 0.04). There was a significant reduction in the incidence of new or worsened hypertension in the REST group (0%) compared with controls (20%, P = 0.02). No difference was seen in the rates of diabetes mellitus, insomnia, LOS, or 30-day readmission rates. CONCLUSIONS: A reduced steroid taper after brain tumor surgery significantly reduced the incidence of hypertension without increasing LOS or 30-day readmissions compared with controls treated with a high-dose taper.
引用
- Breshears JD, Haddad AF, Viner J, et al. A Reduced Exogenous Steroid Taper for Postoperative Brain Tumor Patients-A Case-Control Study. World Neurosurg. 2019. PMID: 30639502. doi:10.1016/j.wneu.2018.12.173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。